Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes

被引:278
作者
Bonnefond, Amelie [1 ,2 ]
Clement, Nathalie [4 ,5 ]
Fawcett, Katherine [6 ]
Yengo, Loic [1 ,2 ]
Vaillant, Emmanuel [1 ,2 ]
Guillaume, Jean-Luc [3 ,4 ,5 ]
Dechaume, Aurelie [1 ,2 ]
Payne, Felicity [6 ]
Roussel, Ronan [7 ,8 ]
Czernichow, Sebastien [9 ,10 ]
Hercberg, Serge [11 ,12 ]
Hadjadj, Samy [13 ,14 ]
Balkau, Beverley [15 ,16 ]
Marre, Michel [7 ,8 ]
Lantieri, Olivier [17 ]
Langenberg, Claudia [18 ]
Bouatia-Naji, Nabila [1 ,2 ]
Charpentier, Guillaume [19 ]
Vaxillaire, Martine [1 ,2 ]
Rocheleau, Ghislain [20 ,21 ]
Wareham, Nicholas J.
Sladek, Robert [22 ,23 ]
McCarthy, Mark I. [24 ,25 ]
Dina, Christian [26 ,27 ,28 ]
Barroso, Ines [6 ,29 ]
Jockers, Ralf [3 ,4 ,5 ]
Froguel, Philippe [1 ,2 ,30 ]
机构
[1] Lille Pasteur Inst, CNRS, Unite Mixte Rech UMR 8199, Lille, France
[2] Lille Nord France Univ, Ecole Doctorale Biol Sante, Lille, France
[3] Inst Cochin, INSERM, U1016, Paris, France
[4] CNRS, UMR 8104, Paris, France
[5] Paris Descartes Univ, Dept Med, Paris, France
[6] Wellcome Trust Sanger Inst, Cambridge, England
[7] Bichat Claude Bernard Univ Hosp, AP HP, Dept Endocrinol Diabetol & Nutr, Paris, France
[8] Univ Paris 07, INSERM, U695, Paris, France
[9] Ambroise Pare Hosp, AP HP, Dept Nutr, Boulogne, France
[10] Univ Versailles Saint Quentin, Unite Format & Rech UFR Sci Sante, Boulogne, France
[11] Univ Paris 13, Ctr Rech Nutr Humaine, Inst Natl Rech Agron, INSERM,U557,U1125, Bobigny, France
[12] Avicenne Hosp, AP HP, Dept Publ Hlth, Bobigny, France
[13] Ctr Hosp Univ Poitiers, Dept Endocrinol & Diabetol, Poitiers, France
[14] Clin Invest Ctr Poitiers Biotheque CIC0802, INSERM, U927, Poitiers, France
[15] Ctr Res Epidemiol & Populat Hlth, INSERM, U780, Villejuif, France
[16] Univ Paris 11, Orsay, France
[17] Inst Interreg Sante IRSA, La Riche, France
[18] Univ Cambridge, MRC, Epidemiol Unit, Inst Metab Sci, Cambridge, England
[19] Corbeil Essonnes Hosp, Dept Endocrinol & Diabetol, Essonnes, France
[20] Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ, Canada
[21] Prognomix, Montreal, PQ, Canada
[22] McGill Univ, Fac Med, Dept Human Genet, Montreal, PQ, Canada
[23] Genome Quebec Innovat Ctr, Montreal, PQ, Canada
[24] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England
[25] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England
[26] Inst Thorax, INSERM, U915, Nantes, France
[27] CNRS, Equipe Rech Labellisee 3147, Nantes, France
[28] Univ Nantes, Dept Biol Med & Hlth, Nantes, France
[29] Univ Cambridge, Addenbrookes Hosp, Metab Res Labs, Inst Metab Sci, Cambridge CB2 2QQ, England
[30] Univ London Imperial Coll Sci Technol & Med, Dept Genom Common Dis, Sch Publ Hlth, Hammersmith Hosp, London, England
基金
英国惠康基金;
关键词
GENOME-WIDE ASSOCIATION; FASTING PLASMA-GLUCOSE; GENERAL-POPULATION; RISK; DISEASES; EXCESS; LOCI;
D O I
10.1038/ng.1053
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Genome-wide association studies have revealed that common noncoding variants in MTNR1B (encoding melatonin receptor 1B, also known as MT2) increase type 2 diabetes (T2D) risk(1,2). Although the strongest association signal was highly significant (P < 1 x 10(-20)), its contribution to T2D risk was modest (odds ratio (OR) of similar to 1.10-1.15)(1-3). We performed large-scale exon resequencing in 7,632 Europeans, including 2,186 individuals with T2D, and identified 40 nonsynonymous variants, including 36 very rare variants (minor allele frequency (MAF) < 0.1%), associated with T2D (OR = 3.31, 95% confidence interval (CI) = 1.78-6.18; P = 1.64 x 10(-4)). A four-tiered functional investigation of all 40 mutants revealed that 14 were nonfunctional and rare (MAF < 1%), and 4 were very rare with complete loss of melatonin binding and signaling capabilities. Among the very rare variants, the partial-or total-loss-of-function variants but not the neutral ones contributed to T2D (OR = 5.67, CI = 2.17-14.82; P = 4.09 x 10(-4)). Genotyping the four complete loss-of-function variants in 11,854 additional individuals revealed their association with T2D risk (8,153 individuals with T2D and 10,100 controls; OR = 3.88, CI = 1.49-10.07; P = 5.37 x 10(-3)). This study establishes a firm functional link between MTNR1B and T2D risk.
引用
收藏
页码:297 / U98
页数:7
相关论文
共 29 条
[1]   A method and server for predicting damaging missense mutations [J].
Adzhubei, Ivan A. ;
Schmidt, Steffen ;
Peshkin, Leonid ;
Ramensky, Vasily E. ;
Gerasimova, Anna ;
Bork, Peer ;
Kondrashov, Alexey S. ;
Sunyaev, Shamil R. .
NATURE METHODS, 2010, 7 (04) :248-249
[2]   Standards of medical care in diabetes 2008 [J].
不详 .
DIABETES CARE, 2008, 31 :S12-S54
[3]   MTNR1B G24E Variant Associates With BMI and Fasting Plasma Glucose in the General Population in Studies of 22,142 Europeans [J].
Andersson, Ehm A. ;
Holst, Birgitte ;
Sparso, Thomas ;
Grarup, Niels ;
Banasik, Karina ;
Holmkvist, Johan ;
Jorgensen, Torben ;
Borch-Johnsen, Knut ;
Egerod, Kristoffer L. ;
Lauritzen, Torsten ;
Sorensen, Thorkild I. A. ;
Bonnefond, Amelie ;
Meyre, David ;
Froguel, Philippe ;
Schwartz, Thue W. ;
Pedersen, Oluf ;
Hansen, Torben .
DIABETES, 2010, 59 (06) :1539-1548
[4]   Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer [J].
Ayoub, MA ;
Couturier, C ;
Lucas-Meunier, E ;
Angers, S ;
Fossier, P ;
Bouvier, M ;
Jockers, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (24) :21522-21528
[5]  
Balkau B, 1996, REV EPIDEMIOL SANTE, V44, P373
[6]   Circadian Integration of Metabolism and Energetics [J].
Bass, Joseph ;
Takahashi, Joseph S. .
SCIENCE, 2010, 330 (6009) :1349-1354
[7]   A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk [J].
Bouatia-Naji, Nabila ;
Bonnefond, Amelie ;
Cavalcanti-Proenca, Christine ;
Sparso, Thomas ;
Holmkvist, Johan ;
Marchand, Marion ;
Delplanque, Jerome ;
Lobbens, Stephane ;
Rocheleau, Ghislain ;
Durand, Emmanuelle ;
De Graeve, Franck ;
Chevre, Jean-Claude ;
Borch-Johnsen, Knut ;
Hartikainen, Anna-Liisa ;
Ruokonen, Aimo ;
Tichet, Jean ;
Marre, Michel ;
Weill, Jacques ;
Heude, Barbara ;
Tauber, Maithe ;
Lemaire, Katleen ;
Schuit, Frans ;
Elliott, Paul ;
Jorgensen, Torben ;
Charpentier, Guillaume ;
Hadjadj, Samy ;
Cauchi, Stephane ;
Vaxillaire, Martine ;
Sladek, Robert ;
Visvikis-Siest, Sophie ;
Balkau, Beverley ;
Levy-Marchal, Claire ;
Pattou, Francois ;
Meyre, David ;
Blakemore, Alexandra I. F. ;
Jarvelin, Marjo-Riita ;
Walley, Andrew J. ;
Hansen, Torben ;
Dina, Christian ;
Pedersen, Oluf ;
Froguel, Philippe .
NATURE GENETICS, 2009, 41 (01) :89-94
[8]   Deep resequencing reveals excess rare recent variants consistent with explosive population growth [J].
Coventry, Alex ;
Bull-Otterson, Lara M. ;
Liu, Xiaoming ;
Clark, Andrew G. ;
Maxwell, Taylor J. ;
Crosby, Jacy ;
Hixson, James E. ;
Rea, Thomas J. ;
Muzny, Donna M. ;
Lewis, Lora R. ;
Wheeler, David A. ;
Sabo, Aniko ;
Lusk, Christine ;
Weiss, Kenneth G. ;
Akbar, Humeira ;
Cree, Andrew ;
Hawes, Alicia C. ;
Newsham, Irene ;
Varghese, Robin T. ;
Villasana, Donna ;
Gross, Shannon ;
Joshi, Vandita ;
Santibanez, Jireh ;
Morgan, Margaret ;
Chang, Kyle ;
Hale, Walker ;
Templeton, Alan R. ;
Boerwinkle, Eric ;
Gibbs, Richard ;
Sing, Charles F. .
NATURE COMMUNICATIONS, 2010, 1
[9]   Reduced Expression of IFIH1 Is Protective for Type 1 Diabetes [J].
Downes, Kate ;
Pekalski, Marcin ;
Angus, Karen L. ;
Hardy, Matthew ;
Nutland, Sarah ;
Smyth, Deborah J. ;
Walker, Neil M. ;
Wallace, Chris ;
Todd, John A. .
PLOS ONE, 2010, 5 (09) :1-6
[10]   International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, Classification, and Pharmacology of G Protein-Coupled Melatonin Receptors [J].
Dubocovich, Margarita L. ;
Delagrange, Philippe ;
Krause, Diana N. ;
Sugden, David ;
Cardinali, Daniel P. ;
Olcese, James .
PHARMACOLOGICAL REVIEWS, 2010, 62 (03) :343-380